Shanghai-listed Chinese drug maker Joincare Pharmaceutical Group Industry has entered into an agreement to raise up to 2.17 billion yuan ($310 million) from Asia-focused Hillhouse Capital Management through a private placement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
